Severe Clotting During Extracorporeal Dialysis Procedures
dc.contributor.author | Boyer, Charles J. | en_US |
dc.contributor.author | Swartz, Richard D. | en_US |
dc.date.accessioned | 2010-06-01T20:27:48Z | |
dc.date.available | 2010-06-01T20:27:48Z | |
dc.date.issued | 1991-04 | en_US |
dc.identifier.citation | Boyer, Charles J.; Swartz, Richard D. (1991). "Severe Clotting During Extracorporeal Dialysis Procedures." Seminars in Dialysis 4(2): 69-71. <http://hdl.handle.net/2027.42/73576> | en_US |
dc.identifier.issn | 0894-0959 | en_US |
dc.identifier.issn | 1525-139X | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73576 | |
dc.format.extent | 444814 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1991 Blackwell Science, Inc. | en_US |
dc.title | Severe Clotting During Extracorporeal Dialysis Procedures | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Division of Nephrology, Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73576/1/j.1525-139X.1991.tb00417.x.pdf | |
dc.identifier.doi | 10.1111/j.1525-139X.1991.tb00417.x | en_US |
dc.identifier.source | Seminars in Dialysis | en_US |
dc.identifier.citedreference | Sanders PW, Taylor H., Curtis JJ: Hemodialysis without anticoagulation. Am J Kidney Dis 5: 32 – 35, 1985. | en_US |
dc.identifier.citedreference | Schwab SJ, Onorato JJ, Sharar LR, Dennis PA: Hemodialysis without anticoagulation: One-year prospective trial in hospitalized patients at risk for bleeding. Am J Med 83: 405 – 410, 1987. | en_US |
dc.identifier.citedreference | Swartz RD, Port FK: Preventing hemorrhage in high-risk hemodialysis: Regional versus low-dose heparin. Kidney Int 16: 513 – 518, 1979. | en_US |
dc.identifier.citedreference | Swartz R.: Hemorrhage during hemodialysis using controlled heparinization. Nephron 28: 65 – 69, 1981. | en_US |
dc.identifier.citedreference | Craddock PR, Fehr J., Brigham K., Kronenberg RS, Jacob HS: Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 296: 769 – 774, 1977. | en_US |
dc.identifier.citedreference | Hakim RM, Breillatt J., Lazarus JM, Port FK: Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 311: 878 – 882, 1984. | en_US |
dc.identifier.citedreference | Hakim RM, Schafer AI: Hemodialysis-associated platelet activation and thrombocytopenia. Am J Med 78: 575 – 580, 1985. | en_US |
dc.identifier.citedreference | Hildebrand U., Quellhorst E.: Influence of various membranes on the coagulation system during dialysis. Contrib Nephrol 46: 92 – 101, 1985. | en_US |
dc.identifier.citedreference | Moll S., De Moerloose P., Reber G., Schifffrli J., Leski M.: Comparison of two hemodialysis membranes, polyacrilonitrile and cellulose acetate, on complement and coagulation systems. Int J Artif Organs 13: 273 – 279, 1990. | en_US |
dc.identifier.citedreference | Notohamiprodjo M., Andrassy K., Bommer J., Ritz E.: Dialysis membranes and coagulation system. Blood Purif 4: 130 – 141, 1986. | en_US |
dc.identifier.citedreference | Berrettini M., Buoncristiani U., Parise P., Ballatori E., Nenci GG: Polyacrilonytrile versus cuprophan membranes for hemodialysis: Evaluation of efficacy and biocompatibility by platelet aggregation studies. Int J Artif Organs 4: 218 – 222, 1981. | en_US |
dc.identifier.citedreference | Sreharan N., Crow MJ, Salter MCP, Donaldson DR, Rajah SM, Davison AM: Membrane effect on platelet function during hemodialysis: A comparison of cuprophan and polycarbonate. Artif Organs 6: 324 – 327, 1982. | en_US |
dc.identifier.citedreference | Docci D., Turci F., Del Vecchio C., Bilancioni R., Cenciotti L., Pretolani E.: Hemodialysis-associated platelet loss: Study of the relative contribution of dialyzer membrane composition and geometry. Int J Artif Organs 7: 337 – 340, 1984. | en_US |
dc.identifier.citedreference | Knudsen F., Nielsen AH: Polycarbonate versus cuprophan dialyzers: Effect on platelet function. Blood Purif 2: 173 – 180, 1984. | en_US |
dc.identifier.citedreference | Vaziri N., Toohey J., Paule P., et al.: Effect of hemodialysis on contact group of coagulation factors, platelets and leukocytes. Am J Med 77: 437 – 441, 1984. | en_US |
dc.identifier.citedreference | Schmitt GW, Moake JL, Rudy CK, Vicks SL, Hamburger RJ: Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Am J Med 83: 411 – 418, 1987. | en_US |
dc.identifier.citedreference | Bjornson J.: Thrombus formation in the artificial kidney. Scand J Urol Nephrol 12: 251 – 257, 1978. | en_US |
dc.identifier.citedreference | Schwarzbeck A., Wagner L., Squarr H-U., Strauch M.: Clotting in dialyzers due to low pH of dialysis fluid. Clin Nephrol 7: 125 – 127, 1977. | en_US |
dc.identifier.citedreference | Bjornson J., Brosstad F.: Platelet and fibrin(ogen) deposition in the artificial kidney: The influence of haematocrit, fibrin monomer and platelet inhibitors. Scand J Urol Nephrol 12: 259 – 264, 1978. | en_US |
dc.identifier.citedreference | Livio M., Benigni A., Remuzzi G.: Coagulation abnormalities in uremia. Semin Nephrol 5: 82 – 90, 1985. | en_US |
dc.identifier.citedreference | Watson AJ: Adverse effects of therapy for the correction of anemia in hemodialysis patients. Semin Nephrol 9 ( Suppl 1 ): 30 – 34, 1989. | en_US |
dc.identifier.citedreference | Bick RL: Clinical relevance of antithrombin III. Semin Thromb Hemost 8: 276 – 287, 1982. | en_US |
dc.identifier.citedreference | Nielsen LE, Bell WR, Borkon AM, Neill CA: Extensive thrombus formation with heparin resistance during extracorporeal circulation. Arch Intern Med 147: 149 – 152, 1987. | en_US |
dc.identifier.citedreference | Marciniak E., Gockerman JP: Heparin-induced decrease in circulating antithrombin-III. Lancet 2: 581 – 584, 1977. | en_US |
dc.identifier.citedreference | Jorgensen KA, Stoffersen E.: Antithrombin III in uremia. Scand J Urol Nephrol 13: 299 – 303, 1979. | en_US |
dc.identifier.citedreference | Knudsen F., Dyerberg J.: Platelets and antithrombin III in uremia: The acute effect of hemodialysis. Scand J Clin Lab Invest 45: 341 – 347, 1985. | en_US |
dc.identifier.citedreference | Toulon P., Jacquot C., Capron L., Frydman M-O., Vignon D., Aiach M.: Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb Haemost 57: 263 – 268, 1987. | en_US |
dc.identifier.citedreference | Brandt P., Jespersen J., Sorensen LH: Antithrombin-III and platelets in haemodialysis patients. Nephron 28: 103, 1981. | en_US |
dc.identifier.citedreference | Matsuo T., Yamada T., Yamanashi T., Kodama K.: Choice of anticoagulant in 9 congenital antithrombin III deficient patients with chronic renal failure undergoing regular hemodialysis. Clin Lab Haematol 11: 213 – 219, 1989. | en_US |
dc.identifier.citedreference | Alegre A., Vicente V., Gonzalez R., Alberca I.: Effect of hemodialysis on protein C levels. Nephron 46: 386 – 387, 1987. | en_US |
dc.identifier.citedreference | Sorensen P., Nielsen A., Knudsen F., Dyerberg J.: Defective protein C in uremia. Blood Purif 5: 29, 1987. | en_US |
dc.identifier.citedreference | Knudsen F., Sorensen PJ, Nielsen AH, Dyerberg J.: Functional impairment of protein C activity during haemodialysis—a new mechanism of extracorporeal thrombogenesis. Blood Purif 7: 230 – 232, 1989. | en_US |
dc.identifier.citedreference | Henke WJ: Protein C and S response to danacrine in end-stage renal disease. Ann Int Med 106: 910, 1988. | en_US |
dc.identifier.citedreference | Mehta R., Scott G., Sloand J., Francis C.: Skin necrosis associated with acquired protein C deficiency in patients with chronic renal failure. Am J Med 88: 252, 1990. | en_US |
dc.identifier.citedreference | Livio M., Mannucci P., Vigano G., et al.: Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med 315: 731, 1986. | en_US |
dc.identifier.citedreference | Byrnes JJ, Larcada A., Moake JL: Thrombosis following desmopressin for uremic bleeding. Am J Hematol 28: 63 – 65, 1988. | en_US |
dc.identifier.citedreference | El-Shahaway MA, Francis R., Akmel M., Massry SG: Recombinant human erythropoietin shortens bleeding time and corrects abnormal platelet aggregation in hemodialysis patients (Abstract). J Amer Soc Nephrol 1: 397, 1990. | en_US |
dc.identifier.citedreference | Babcock RB, Dumper CW, Scharfman WB: Heparin-induced immune thrombocytopenia. N Engl J Med 295: 237 – 241, 1976. | en_US |
dc.identifier.citedreference | King DJ, Kelton JG: Heparin-associated thrombocytopenia. Ann Int Med 100: 535 – 540, 1984. | en_US |
dc.identifier.citedreference | Selli C., Amato M., Salvadori M.: Priapism associated with chronic hemodialysis. Dial Transpl 15: 101, 1986. | en_US |
dc.identifier.citedreference | Pusineri F., Bini A., Mussoni L., et al.: Intermittent heparinization does not induce hypercoagulability in haemodialysis patients. J Clin Pathol 33: 631, 1980. | en_US |
dc.identifier.citedreference | Habbib M., Haft J.: Heparin resistance induced by intravenous nitroglycerin: A word of caution when both drugs are used concomitantly. Arch Int Med 147: 857, 1987. | en_US |
dc.identifier.citedreference | Penner JA: Hypercoagulation and thrombosis. Med Clin North Am 64: 743 – 759, 1980. | en_US |
dc.identifier.citedreference | Kelly A., Hanson J., Henderson L., Harker L.: Prevention of heparinresistant thrombotic occlusion of hollow fiber hemodialyzers by synthetic antithrombin III. J Lab Clin Med 114: 411, 1989. | en_US |
dc.identifier.citedreference | Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkoff-Rubin N.: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304: 934 – 939, 1981. | en_US |
dc.identifier.citedreference | Smith MC, Danviriyasup K., Crow JW, Cato AE, Park GD, Hassid A., Dunn MJ: Prostacyclin substitution for heparin in long-term hemodialysis. Am J Med 73: 669 – 678, 1982. | en_US |
dc.identifier.citedreference | Swartz R., Flamenbaum W., Dubrow A., et al.: Epoprostenol (PG12; prostacyclin) during high-risk hemodialysis: Preventing further bleeding complications. J Clin Pharmacol 28: 818, 1988. | en_US |
dc.identifier.citedreference | Woods H., Ash G., Parsons V., Weston M.: Reduction of dialyzer deposition with sulphinpyrazone. Clin Nephrol 12: 122, 1979. | en_US |
dc.identifier.citedreference | Maurin N., Ballmann M.: Prevention of coagulation during hemodialysis by a combination of the stable prostacyclin analogue CG 4203 and low-dose heparin. Clin Nephrol 30: 35, 1988. | en_US |
dc.identifier.citedreference | Henny C., Ten Cate H., Surachno S., et al.: The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis. Thromb Haemost 54: 460, 1985. | en_US |
dc.identifier.citedreference | Pinnick R., Weigmann T., Diderich D.: Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 308: 258, 1983. | en_US |
dc.identifier.citedreference | Mehta RL, McDonald BR, Aguilar MM, Ward DM: Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 38: 976 – 981, 1990. | en_US |
dc.identifier.citedreference | Toomasian JM, Helmer GA, Zeme MI, Oltean JN, Oran AD, Bartlett RH: Control of thrombosis in extracorporeal circulation: Variations of anticoagulation. Trans Am Soc Artif Organs 29: 206 – 209, 1983. | en_US |
dc.identifier.citedreference | Langer R., Linhardt RJ, Hoffberg S., Larsen AK, Cooney CL, Tapper D., Klein M.: An enzymatic system for removing heparin in extracorporeal therapy. Science 217: 261 – 263, 1982. | en_US |
dc.identifier.citedreference | Teng C-LC, Kim J-S., Port FK, Wakefield TW, Till GO, Yang VC: A protamine filter for extracorporeal blood heparin removal. Trans Am Soc Artif Organs 34: 743 – 746, 1988. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.